Cytogenetically, testicular germ cell tumors of adolescents and adults (TGCTs) are characterized by gain of 12p-sequences, most often through isochromosome formation (i(12p)). Fluorescence in situ hybridization (FISH) has shown that i(12p))-negative TGCTs also cryptically contain extra 12p-sequences. The consistency of 12p-over-representation in all histological subtypes of TGCTs, including their preinvasive stage, suggests that gain of one or more genes on 12p is crucial in the development of this cancer. So far, studies aimed at the identi®cation of the relevant gene(s) were based on thè candidate-gene approach'. No convincing evidence in favor of or against a particular gene has been reported. We combined conventional karyotyping, comparative genomic hybridization, and FISH to identify TGCTs with ampli®cations of restricted regions of 12p. Out of 49 primary TGCTs (23 without i(12p), 13 with and 13 unknown), eight tumors (six without i(12p) and two unknown) showed ampli®cations corresponding to 12p11.1-p12.1. Using bicolour-FISH, physical mapping, and semi-quantitative polymerase chain reactions, the size of the shortest region of overlap of ampli®cation (SROA) was estimated to be between 1750 ± 3000 kb. In addition, we mapped a number of genes in and around this region. While fourteen known genes could be excluded as candidates based on their location outside this region, we demonstrate that KRAS2, JAW1 and SOX5 genes are localized within the SROA. While KRAS2 and JAW1 map to the proximal border of the SROA, SOX5 maps centrally in the SROA. KRAS2 and JAW1 are expressed in all TGCTs, whereas one 12p amplicon-positive TGCT lacks expression of SOX5. The critical region of 12p over-represented in TGCTs is less than 8% of the total length of the short arm of chromosome 12. It will be helpful in the identi®cation of the gene(s) involved in TGCT-development.
Cytogenetically, testicular germ cell tumors of adolescents and adults (TGCTs) are characterized by gain of 12p-sequences, most often through isochromosome formation (i(12p)). Fluorescence in situ hybridization (FISH) has shown that i(12p))-negative TGCTs also cryptically contain extra 12p-sequences. The consistency of 12p-over-representation in all histological subtypes of TGCTs, including their preinvasive stage, suggests that gain of one or more genes on 12p is crucial in the development of this cancer. So far, studies aimed at the identi®cation of the relevant gene(s) were based on thè candidate-gene approach'. No convincing evidence in favor of or against a particular gene has been reported. We combined conventional karyotyping, comparative genomic hybridization, and FISH to identify TGCTs with ampli®cations of restricted regions of 12p. Out of 49 primary TGCTs (23 without i(12p), 13 with and 13 unknown), eight tumors (six without i(12p) and two unknown) showed ampli®cations corresponding to 12p11.1-p12.1. Using bicolour-FISH, physical mapping, and semi-quantitative polymerase chain reactions, the size of the shortest region of overlap of ampli®cation (SROA) was estimated to be between 1750 ± 3000 kb. In addition, we mapped a number of genes in and around this region. While fourteen known genes could be excluded as candidates based on their location outside this region, we demonstrate that KRAS2, JAW1 and SOX5 genes are localized within the SROA. While KRAS2 and JAW1 map to the proximal border of theIntroduction Testicular germ cell tumors of adolescents and adults (TGCTs) are the most common cancer in Caucasian males in the age between 15 and 45 years, and an increasing incidence has been reported in most European countries as well as in the USA (Adami et al., 1994; Mùller et al., 1995; Feuer, 1995; BergstroÈ m et al., 1996; Bosl et al., 1997) . Histologically and clinically they can be divided into two main groups, the seminomas (SE) and the nonseminomatous-TGCTs (NS) (Mosto® et al., 1987) . Both types of TGCTs originate from a common precursor, known as carcinoma in situ (Skakkebñk et al., 1987) or intratubular germ cell neoplasia (Stamp and Jacobsen, 1995) . A large number of TGCTs, both primary and metastatic, of various histologies have been studied for their chromosomal constitution by dierent investigators, including ourselves (Rodriquez et al., 1993a; Van Echten et al., 1995; Sandberg et al., 1996, for review) . Besides non-random patterns of over-and underrepresentation of (parts of) chromosomes, gain of 12p is a consistent ®nding. In the majority of TGCTs tested this was due to the presence of one or more copies of isochromosome 12p [i(12p) ]. In addition, it was found using¯uorescence in situ hybridization (FISH) that TGCTs without i(12p) always show overrepresentation of 12p-sequences cryptically hidden in the genome (Suijkerbuijk et al., 1993; Rodriquez et al., 1993b; Smolarek et al., 1995) . We showed that i(12p) may also be present in CIS (Vos et al., 1990) , indicating that over-representation of 12p-sequences is probably a relatively early event in the pathogenesis of this cancer, not related to invasive growth. We con®rmed this by numerical analysis on tissue sections using in situ hybridization (Looijenga et al., 1993; Gillis et al., 1994) .
Although more than 14 years have passed since the ®rst publication of i(12p) as a speci®c chromosomal abnormality for TGCTs (Atkin and Baker, 1983) , ideas on the critical target gene(s) still remain speculative. This can be explained by the fact that most TGCTs show over-representation of the complete short arm of chromosome 12, encompassing approximately 40 Megabases (Mb) and containing theoretically between 850 and 1400 genes (Marynen and Kucherlapati, 1996) . Therefore, alternative approaches are required to identify the gene(s) on 12p of which copy-gain is bene®cial for the development of TGCTs. One possible strategy was initiated by our previous identi®cation of a metastatic SE showing ampli®cation of a restricted region of 12p (Suijkerbuijk et al., 1994) . More recently, we and others demonstrated via comparative genomic hybridization (CGH), a technique developed to identify relative (sub-) chromosomal gains and losses (Kallioniemi et al., 1992) , that also a certain percentage of primary TGCTs shows ampli®cation of a restricted region of 12p, cytogenetically similar to the one observed before (Mostert et al., 1996a; Korn et al., 1996) . This ®nding of a restricted 12p-ampli®cation allows identi®cation of relevant genes using a direct approach.
To determine the shortest region of overlap of ampli®cation (SROA) of 12p in TGCTs we combined conventional karyotyping, CGH, (bicolour-)FISH, physical mapping, and semi-quantitative polymerase chain reaction (PCR) analyses. Identi®cation of such a SROA allows the exclusion of a number of known genes on 12p as candidates, and will facilitate a more direct approach to identify novel genes on 12p critical to the pathogenesis of this cancer.
Results

Detection of 12p-ampli®cation
To identify cases with a restricted ampli®ed region of 12p, we used CGH to screen a series of 49 primary TGCTs, including 26 SE and 23 NS, of which 23 lacked i(12p) by conventional karyotyping (13 SE and 10 NS). In 13 tumors i(12p) was identi®ed and 13 tumors could not be analysed due to lack of metaphases. Eight tumors (six lacking i(12p) and two unknown) showed ampli®cation of a part of 12p detectable by CGH, identi®ed as region 12p11.1-p12.1, similar to the previously reported case of a metastatic SE (Suijkerbuijk et al., 1994) . Four tumors were classi®ed as SE (T2655, T2814, T8763 and T202)  and four as NS (T10077, T3035, T2207 and T60) . Tumors T2207 and T60 are NS with a SE-component, socalled combined tumors according to the British classi®cation (Pugh, 1976) . The ampli®cation was found in both SE components, and in only one of the NS components (not shown).
Six of these tumors with ampli®cation (T2655, T2814, T8763, T10077, T3035 and T2207) were karyotyped successfully. The metaphases were further analysed by FISH with a Yeast Arti®cial Chromosome probe, known as YAC#5 which was formerly mapped to region 12p11.2-p12.1 (Suijkerbuijk et al., 1994) . This probe was used since it allowed the detection of gain of 12p-sequences in all TGCTs tested so far (unpublished observations). It was found that the ampli®cations were due to the presence of additional 12p-sequences in add(12)(p13) or der(12)t(12;?;hsr)(p13;?;?) in T10077, add(12)(p13) in T2655, add(12)(p12) in T2814, der(6;?17)(q10;q10)add(6)(q21) and a marker (which was cytogenetically identi®ed as an i(8)(q10)) in T8763 (not shown). In the remaining two tumors there were no metaphases suitable for FISH.
All eight TGCTs with a proven restricted amplification of 12p by CGH were studied by FISH using YAC#5 on interphase nuclei. This probe showed between 15 ± 30 hybridization signals per nucleus in these tumors as reported before in other TGCTs (Suijkerbuijk et al., 1994; Mostert et al., 1996b; Korn et al., 1996) . Circumstantial evidence that YAC#5 indeed maps within (or at least close to) the critically ampli®ed region was obtained by combining CGH on tumor T2207 with FISH of YAC#5: YAC#5 hybridization co-incided exactly with the ampli®ed 12p-region, both in metaphase spreads and interphase nuclei (not shown). Of the samples T2655 and T2207 suitable material for further FISH analysis was lacking, because only a small part of tumor cell nuclei contained the 12p-ampli®cation. The 12p-amplicon negative nuclei in these particular tumors however, also contained extra 12p sequences identi®able with FISH, although in a lower total copy number. In which form these sequences were present could not be determined due to lack of metaphases. Using FISH with YAC#5 in combination with a probe speci®c for the centromeric region of chromosome 12 (Looijenga et al., 1990) we checked the remaining 41 TGCTs for 12p-ampli®cation. This approach showed no indications that ampli®cation of a restricted region (containing YAC#5) was missed by the procedure followed.
Construction of a YAC-contig of 12p11.2-p12.1 region and mapping of YAC#5 YAC#5, previously mapped to 12p11.2-p12.1 (Suijkerbuijk et al., 1994) , was used as a starting point to generate a contig suitable to determine the SROA. The most relevant part of the contig is shown in Figure 1a . The length of the dierent YACs was estimated by pulsed-®eld gel electrophoresis. The presence or absence of STS markers was checked by PCR using STS speci®c primer sets on the relevant YACs. Both proximal and distal directions were analysed until a YAC was proven to be negative for the next STS. The assumed order of STS markers was in agreement with the data from the Whitehead Institute database. The seeming contradiction in length of YACs 803B2, 845D11 and 957B7, which all are positive for the same markers (see Figure 1a) , is most probably due to chimerism of the YACs 803B2 and 845D11, as these YACs also score positive with markers of other chromosomes than chromosome 12. YAC#5 was placed on the contig by inter-Alu ®ngerprinting and by Southern blot hybridization of a YAC#5 interAlu probe (not shown). As indicated, YAC#5 was found to overlap with YACs 922D9, 928G2 and 753F12. In addition, YAC#5 was positive for STS D12S1057 by PCR, which secured YAC#5 to a ®xed position on the map. Furthermore, a number of cosmids speci®c for dierent STSs within the contig were isolated ( Figure  1a ).
Shortest region of overlap of ampli®cation (SROA)
To de®ne the borders of the SROA, the six remaining 12p ampli®cation-positive tumors were studied using bicolour-FISH, as reported before (Mostert et al., 1996b) . Therefore, dierent YACs and cosmids within the contig were hybridized simultaneously with YAC#5 on interphase nuclei isolated from the tumors. YAC#5 was visualized in green and the other probes in red. The number of signals per interphase nucleus, and metaphase spread if available, was scored. The results are summarized in Figure 1b . None of the YACs tested showed higher numbers of signals than YAC#5, indicating that the region showing the highest level of ampli®cation includes sequences recognized by YAC#5. For all tumors similar signal numbers were found for YAC#5 and YACs 927G11, 922D9 and 753F12. In contrast, at the telomeric side, YAC 803B2 showed signi®cantly fewer signals than YAC#5 in T10077, whereas on the centromeric side YAC 744G11 showed signi®cantly less signals in T60 and T8763. Due to the sizes of the dierent YACs used (indicated in Figure 1a ), the exact borders of the amplicon could not be determined accurately. Therefore, a number of cosmids (speci®c for STSs localized in the putative border regions of the amplicon) were used in a similar bicolour-FISH approach as described above with YAC#5. The results are also indicated in Figure 1b and a representative example is shown in Figure 2 . In the distal region, cosmid 235C1, containing STS D12S1945, showed fewer signals than YAC#5 in T10077, T8763 and T202. About 25% of the nuclei of the latter tumor showed this dierence, while the majority of nuclei had similar copy numbers. FISH with cosmid 34F8, containing D12S1688, showed the same pattern as with 235C1 in T10077 while cosmid 95C2, speci®c for AFM267yc9, demonstrated an equal number of signals as with YAC#5. The data indicate that the distal border of the SROA maps between the STSs D12S1688 and AFM267yc9.
At the proximal side fewer signals than with YAC#5 were found in four of the tumors with cosmid 164F2 (containing STS D12S1325), in three tumors with 124A3 (containing STS D12S1411), in two tumors with both 177G11 (containing STS D12S1034) and 52C10 (containing STS D12S1313). Cosmid 31C2 (containing STS D12S1350E) showed similar signal numbers as with YAC#5. The data indicate that the proximal border of the SROA lies between D12S1350E and D12S1313.
It can be concluded that based on this set of tumors, the SROA lies between D12S1688 at the distal end and D12S1313 at the proximal end. More tumors containing smaller 12p-ampli®cations have to be identi®ed and studied to further narrow the SROA.
Candidate genes and semi-quantitative (RT ± PCR)
A number of genes have been mapped to the region 12p11-p13, as summarized in Table 1 . These can be considered as candidates to explain gain of 12p-sequences in TGCTs. We were able to map the genes (from distal to proximal), RECQL, IAPP, LGS, LDHB, SOX5, JAW1, KRAS2, KRAG, ITPR2, PTHLH and LGP within the contig ( Figure 1a ).
LGS ( PTHLH (Raeymaekers et al., 1995) and LGP (Newgard et al., 1986) have been localized as part of a long term project to map all known human genes and ESTs (Krauter et al., 1995 , and http://www genome.wi.mit.edu). YAC ICI36ECI was the smallest YAC found to be positive for KRAG by PCR, placing this gene between STS D12S1596 and D12S1316. The human DNA helicase Q1 (RECQL) (Seki et al., 1994; Puranam, 1995) , the islet amyloid polypeptide (IAPP) (Hoovers et al., 1993) and lactate dehydrogenase isoenzyme B (LDHB) genes (Li et al., 1988) were previously mapped to band 12p12. We were able to localize these genes to the distal part of our YAC contig ( Figure 1a ) and their order was determined by PCR on the dierent YACs.
Three genes, SOX5, JAW1 and KRAS2 were found to map within the SROA. KRAS2 was previously mapped between markers D12S1435 and D12S1596 (Krauter et al., 1995) . PCR with KRAS2 speci®c primers showed that proper ampli®cation products were generated from YACs 753F12 and 761B8, while no signals were obtained using YACs 928G2 and 744G11. This observation places KRAS2 between the markers D12S1350E and D12S1313. This localization was con®rmed by Southern blot analysis using a KRAS2 speci®c probe (not shown). Our data demonstrate that KRAS2 is localized just at the proximal border of the SROA (see Figure 1 ). Bicolour-FISH using YAC#5 and a cosmid containing KRAS2 showed that this region was indeed ampli®ed at the same level as YAC#5 in all tumors. SOX5 was previously mapped to 12p12.1 by FISH (Wunderle et al., 1996) . Southern blot analysis with an inter-Alu speci®c fragment of YAC y900G1253, which contains the SOX5 gene (Wunderle et al., 1996) , showed only hybridization with YAC 922D9 (not shown). PCR with SOX5 speci®c primers con®rmed localization of this gene on both YAC 922D9 and y900G1253. In addition, YAC y900G1253 scored positive for STSs D12S1942 and D12S1950. Therefore, we conclude that SOX5 maps between the markers AFMB351ZH5 and D12S1591 (illustrated in Figure 1a) . A sequence homology search with markers from our contig showed 100% identity of STS D12S1350E with the JAW1 gene.
As an additional approach to de®ne the SROA, semi-quantitative PCR-analyses were performed on ®ve TGCTs with a 12p-amplicon (T10077, T3035, T2814, T60 and T8763) to study dierences in copy numbers of genes mapping to the region of interest: i.e., LGS, KRAS2, KRAG and ITPR2 (Figure 3 ). Two non-12p genes were included as references (ProgR and 17pTEL), which revealed similar results. No clear dierences in copy numbers of the tested genes on 12p were found in TGCTs without 12p-amplicons that were used as controls (not shown). Also, no unbalances were found between the 12p-genes themselves in T2814, which is in agreement with the results of the bicolour-FISH experiments. While all 12p genes tested showed over-representation at least to some degree relative to ProgR and 17pTEL in T10077, T3035 and T2814, no a b Figure 2 Example of bicolour¯uorescence in situ hybridization on isolated nuclei from tumor T8763, showing (a) similar signal numbers using YAC#5 (detected in green) and cosmid 31C2 (containing STS D12S1350E) (detected in red) as probes; and (b) a lower signal number for cosmid 124A3, speci®c for STS D12S1411 (detected in red) as compared to YAC#5 (detected in green). Signals for the cosmids (in red) are larger than the signals for the YACs (in green) because of a biotinyl-tyramide ampli®cation step used to visualize the cosmids gain of KRAG and ITPR2 was found in T60 and T8763, again concordant with the results obtained by bicolour-FISH. This indicates that this region of 12p is not included in the amplicons in these particular LGS versus ProgR but the degree of ampli®cation seems to be reduced compared to KRAS2 levels. Tracks: 1, 2, 4, 5 = DNA derived from normal lung tissue; 3 = T8763; 6 = negative control (no target DNA); 7 = éX174/HaeIII marker tumors (see Figure 1b) . The results suggest that in both cases a region encoding KRAS2 but excluding KRAG/ ITPR2 is preferentially ampli®ed. The fact that LGS has a similar level in PCR-ampli®cation in tumor T60 as in tumor T8763 is most likely explained by the relatively low percentage of tumor cells containing the smallest ampli®ed region on 12p in the latter sample as demonstrated by FISH with cosmid 235C1. In addition, the levels of ampli®cation of PTHLH and ITPR2 relative to KRAS2 were determined. No dierences were found between ITPR2 and KRAS2 in the tumors T10077, T3035 and T2814, again in agreement with the bicolour-FISH results (Figure 1b) . ITPR2 was not found to be ampli®ed in tumors T60 and T8763. When comparing KRAS2 with PTHLH, four of the tumors (T3035, T2814, T60 and T8763) showed a higher ampli®cation of KRAS2, also concordant with the data obtained by bicolour-FISH. Although the bicolour-FISH with YAC#5 and cosmid 34F8 showed dierences in signal numbers in tumor T10077 (Figure 1b) , no dierences in levels of PCRampli®cation as compared to KRAS2 were found with speci®c primers for STS D12S1688, for which 34F8 is positive. The dierences between double-FISH and PCR could be due to the heterogeneity in length and number of the amplicons and the dierence in sensitivity of both methods to detect them. No dierence in level of PCR-ampli®cation compared to KRAS2 was found for the STSs D12S1606 and D12S1596 in tumors T10077, T60 and T8763. As the localization of SOX5 and JAW1 was identi®ed at a later stage during our investigation, these were not included in the semi-quantitative analysis.
In order to study the expression of the SOX5 and KRAS2 genes mapped within the SROA, a semiquantitative reverse transcription (RT ± PCR) was performed. As illustrated in Figure 4 , most tumors with ampli®cation of a restricted region of 12p showed a similar level of expression of KRAS2. In one tumor a lower level was found. In contrast, a more heterogeneous pattern of expression was found for SOX5. In four tumors it was expressed at a lower level than KRAS2, and in two at a higher level. In addition, no expression of SOX5 could be detected in T8763. To exclude loss of this particular genomic fragment in the amplicon, we performed FISH with a YAC containing SOX5 (y900G1253) simultaneously with YAC#5. Similar numbers of signals of both probes were detected in the tumors with 12p-ampli®cation. All control samples of normal testis parenchyma and parenchyma samples with dierent amounts of carcinoma in situ cells tested showed expression of both KRAS2 and SOX5 (not shown). For JAW1 relatively high expression was found in the tumors containing a 12p-ampli®cation, but also in TGCTs without such an amplicon (not shown). In addition, expression of this gene was also detected in normal testis and placenta.
Discussion
One of the most important problems in the study of the pathogenesis of TGCTs is the identi®cation of the tumor biologically relevant gene or genes in the overrepresented region of 12p. It has been known for more than a decade that the majority of TGCTs contains one or more isochromosomes of the short arm of chromosome 12 (Mukherjee et al., 1991; Rodriquez et al., 1993a; Van Echten et al., 1995; Mostert et al., 1996b) . Moreover, it has been demonstrated, that TGCTs without i(12p) also show over-representation of 12p-sequences (Suijkerbuijk et al., 1993; Rodriquez et al., 1993b; Smolarek et al., 1995) . Since in those studies a paint for the whole short arm of chromosome 12 was used, or a probe which was not mapped in detail, it was not possible to localize the region involved. The ®nding of ampli®cation of a restricted region of 12p in a case of metastatic SE (Suijkerbuijk et al., 1994) was a key observation. More recently, we and others reported the presence of similar amplifications in several primary TGCTs (Mostert et al., 1996a; Korn et al., 1996) . Apparently gain of 12p-sequences by means of ampli®cation of a smaller region of 12p (instead of i(12p)-formation) is not restricted to metastatic lesions.
We found ampli®cation of a limited region of 12p in eight out of 49 primary TGCTs. In this relatively small and selected sample it occurred in SE as well as NS, suggesting that this type of ampli®cation is not correlated with the histology of the TGCT. Amplification of a restricted region of 12p was preferentially found in TGCTs without i(12p) (six out of 23 cases (26%) and none out of 13 TGCTs with i(12p)). We demonstrate that the borders of the 12p-amplicon vary in dierent TGCTs, thereby de®ning the SROA as the region of interest. By assuming that the STSs are equally divided over the YACs 753F12, 922D9 and 957B7, we estimate that the SROA could be as small as 1750 kb. However, when the average distance between markers on chromosome 12 is 248 kb as suggested by Krauter et al. (1995) the SROA could be as large as 3000 kb. Although this is still a relatively large fragment, it drastically reduces the crucial region on the short arm of chromosome 12 involved in the pathogenesis of TGCTs.
Identi®cation of this SROA permits the selection of the most likely genes involved in the pathogenesis of TGCTs. For example, cyclin D2 (CCND2), mapped to 12p13 (Inaba et al., 1992) gene of interest (Sicinski et al., 1996; Houldsworth et al., 1997) . We demonstrated by Southern blot analysis using a cDNA probe on all YACs within that region that cyclin D2 maps outside the SROA (not shown). Obviously, cyclin D2 is not likely to be the gene explaining the gain of 12p-sequences in TGCTs. The published ®ndings support this view, because this gene is preferentially expressed in yolk sac tumors and not for example in embryonal carcinoma cell lines (Sicinski et al., 1996) , being representative for the stem cells of NS (Andrews et al., 1990) . The fact that the presence of the cyclin D2 in NS depends on the histology (Houldsworth et al., 1997) is neutral with respect to the hypothesis that cyclin D2 is the gene of interest. Overrepresentation of the cyclin D2 gene in most of the TGCTs and derived cell lines (Sicinski et al., 1996) probably merely re¯ects the over-representation of the complete short arm of chromosome 12 found in virtually all TGCTs (Mukherjee et al., 1991; Rodriquez et al., 1993a,b; Van Echten et al., 1995; Mostert et al., 1996b) . A number of other genes previously proposed as candidates we also considered less likely because they map outside the SROA (Table 1) . Some of these candidates were plausible, like LGS, encoding the rate limiting enzyme in the synthesis of glycogen (Nuttall et al., 1994) and LDHB, encoding lactate dehydrogenase type B (Li et al., 1988) . Glycogen is found abundantly in carcinoma in situ and the majority of the dierent invasive components (Mosto® et al., 1987) . LDHB is used as a serum marker for TGCTs, in which its level seems to correlate with the copy numbers of the short arm of chromosome 12 (Taylor et al., 1986; Von Eyben et al., 1988 , 1992 . TNFR1, also located on 12p13 (Fuchs et al., 1992; Krauter et al., 1995) might be a candidate because mouse primordial germ cells, the mouse equivalent of the normal human counterpart of carcinoma in situ and SE, show proliferation after TNF exposure (Kawase et al., 1994) . However, LGS, LDHB and TNFR1 map outside the SROA. We reduced the size of the crucial region on 12p to a minimal length of about 1750 kb. Theoretically, between 25 ± 50 genes could be present within such a stretch of DNA. However, SOX5, JAW1 and KRAS2 are the only genes which were so far mapped within this SROA (Popescu et al., 1985; Wunderle et al., 1996 and this manuscript). The human SOX5 gene was only very recently described. Studies in the adult mouse showed expression of this gene in haploid round spermatids, where the protein may function as a transcription factor. Human SOX5 transcripts have been found in adult testis, heart, liver, lung, kidney, spleen and fetal brain. Because we found one TGCT without expression of this gene, SOX5 does not seem to be the gene of interest. Involvement of KRAS2 in the pathogenesis of TGCTs has been suggested and questioned by dierent investigators and its role is largely unclear so far (Dmitrovsky et al., 1990; Moul et al., 1992; Olie et al., 1995) . Moreover, it has been reported that activation of KRAS2 is not sucient for malignant transformation (Kumar et al., 1990; Rodenhuis, 1992; McCormick, 1994) .
Jaw1 is expressed in a developmental stage-speci®c fashion in both mouse B-and T-lymphocyte lineages, with the highest expression levels found in pre-B cells, mature B cells and pre-T cells (Behrens et al., 1994 (Behrens et al., , 1996 . No detectable expression was found in nonhematopoietic cell lines. The encoded protein is localized on the cytoplasmic face of the endoplasmatic reticulum (Behrens et al., 1994 (Behrens et al., , 1996 . The exact function of this protein is not yet known and the role it might have in cancer pathogenesis is not clear. The JAW1 expression as we found in TGCTs might be related to lymphocytic in®ltrations, which are most profoundly present in SE (Mosto® et al., 1987) , although expression of this gene was also found in NS, which are known to contain signi®cantly less lymphocytic in®ltrates (Mosto® et al., 1987) .
Gain of 12p-sequences as an initiating event in the pathogenesis of TGCTs seems unlikely, because we reported that polyploidization, resulting in consistent aneuploidy of TGCTs Looijenga et al., 1991) , precedes i(12p) formation (Geurts van Kessel et al., 1989) and, therefore, probably also ampli®cation of 12p-sequences. This ®nding and the fact that ampli®cations of 12p sequences within one TGCT can be heterogeneous suggests that the increasing copy number is a progression-related phenomenon. This indicates that the pathogenesis of TGCTs is not a single step process. To this day it remains to be elucidated why a number of tumors preferentially amplify a speci®c region of 12p in contrast to gain of the complete short arm as found in the majority of TGCTs. Proving that SOX5, JAW1, KRAS2, or any other gene mapping within the SROA is the biologically relevant gene for the development of TGCTs, requires more extensive expression analyses at dierent developmental stages during the pathogenesis of TGCTs, and the development of proper in vitro and in vivo model systems to test these genes.
In conclusion, we report on the reduction of the region on the short arm of chromosome 12 crucial in the pathogenesis of TGCTs to 1750 ± 3000 kb. This will facilitate the development of assays for the early identi®cation of this chromosomal anomaly and moreover, the amplicon on 12p is a starting point for cloning and characterizing novel genes, which by their mere presence in this region are potential candidate genes.
Materials and methods
Samples
The TGCTs included in this study were collected at the operating theatre in collaboration with Urology-and Pathology-departments in the South-Western part of the Netherlands. After incision of the orchidectomy-specimen, representative samples of the tumor and adjacent parenchyma (when available) were snap frozen in liquid nitrogen, and formaline-®xed and subsequently paran embedded for histological examination. The tumors were classi®ed according to the World Health Organization classi®cation for testicular tumors (Mosto® and Price, 1973) .
Slide preparation for conventional chromosome banding, FISH and CGH
After surgical removal, representative parts of SE were directly handled to isolate metaphase spreads as described before . Brie¯y, the mitotic cells were, after mechanical dissociation of the tumor, directly harvested in the presence of colcemid (Life Technologies). The cells were subsequently swollen in hypotonic KCl/ EGTA/Hepes solution and ®xed with methanol-acetic acid (3 : 1). Representative parts of NS were enzymatically digested (collagenase, Sigma), and short term cultured in T75¯asks (Costar) under standard conditions, i.e., 378C, 5% CO 2 in air humidi®ed atmosphere in DMEM/HF12 with 10% heat-inactivated FCS (BRL ± GIBCO). Mitotic cells were harvested after 2 ± 4 h of colcemid treatment, again swollen in hypotonic solution and ®xed in methanol : acetic acid. For conventional karyotyping, airdried preparations were banded with pancreatin (Sigma) as reported previously (Mostert et al., 1996b) . The chromosome constitution was described according to the International System for Human Cytogenetic Nomenclature 1995 (Mitelman, 1995) .
Slides for single-and bicolour-FISH were either prepared from methanol-acetic acid ®xed material as reported previously (Mostert et al., 1996b) , or from nuclei isolated from frozen material. For the latter method ten frozen tissue sections of 50 mm thickness, of a histologically checked sample, were resuspended in 1 ml PBS by pipetting. The nuclei were directly ®xed by adding 70% ethanol (7208C). After centrifugation for 10 min at 1200 r.p.m., the supernatant was replaced by 5 ml 70% fresh ethanol (7208C). Finally, ®xed suspensions were dropped on slides, air dried and baked for 30 min at 658C.
For CGH, metaphase spreads were prepared using standard procedures from in vitro phytohemagglutininstimulated peripheral blood lymphocyte cultures of a healthy male (46,XY), as reported before (Mostert et al., 1996a) .
Comparative genomic hybridization
High molecular weight DNAs were isolated from histologically checked samples using standard procedures (proteinase K-sodium dodecyl sulphate treatment followed by phenol-chloroform extraction and ethanol precipitation (Maniatis et al., 1982) ). CGH was performed as described (Mostert et al., 1996a ) with a few modi®cations. For each hybridization, 200 ng lissamine-labeled (11-dUTP, Dupont) control male DNA and 200 ng digoxigenin-labeled (11-dUTP, Boehringer Mannheim) tumor DNA and 10 mg COT 1 DNA dissolved in 10 ml standard hybridization mixture were hybridized to normal metaphases and incubated at 378C for 4 days. The hybridized slides were washed three times with 26 SSC at 378C followed by 0.16 SSC at 608C (three washes). Fluorescence detection of the tumor DNA was accomplished using one layer of antidigoxigenin-FITC (Boehringer Mannheim). The slides were mounted in antifade (Vectashield) containing 4,6-diamidino-2-phenylindole (DAPI, Sigma) for counterstaining of the chromosomes.
The results were evaluated using an epi¯uorescence microscope (Leica DM) equipped with a cooled CCD camera (Photometrics, Tucson, AZ), a triple band pass beam splitter and emission ®lters (P-1 ®lter set, Chroma Technology). Images were saved using a routine built up in SCIL ± Image implemented on a Power Macintosh 8100. Image analyses were performed with the use of QUIPS XL software (Vysis Inc. Downers Grove, IL). The green and red uorescent intensities were measured with the Xwoolz software for a Sun work station. In the ®rst experiment the normalization was carried out as described before (Mostert et al., 1996a) , by using the average of the green to red uorescent intensities for the entire metaphase. Regions that showed variations in centromeric and heterochromatic regions (chromosome 1, 9, 16 and Y) and the immediate telomeric regions were omitted from analysis.
Yeast arti®cial chromosomes; origin and characterization YAC#5 was kindly provided by Dr B Gemmill (Denver, USA). The SOX5 containing YAC ICRFy900G1253 was obtained through the Resource Center in Berlin. YAC ICI36EC1 was obtained by Dr J Heighway. All other YACs used are from the CEPH mega-YAC library (contig WC 12.1) and were obtained through the Leiden YAC Screening Centre. YAC clones were grown and DNA was isolated according to standard protocols (Mostert et al., 1996b) . Proper localization of the YACs was tested by FISH on normal human lymphocytes. The length of the YACs was determined by pulsed ®eld gel electrophoresis.
Inter-Alu PCR on YAC#5 and other YACs from the contig was performed using primers ALUI and ALUIV (Cotter et al., 1991) .
STS and cosmids
Cosmids mapping within the contig were isolated from a chromosome 12 speci®c library by hybridization of spotted ®lters with ampli®ed fragments generated by PCR using STS-speci®c primer products isolated from normal human placenta. The STS-speci®c primer sequences were obtained from the Whitehead Institute for Biomedical Research database, and additional information (localization, polymorphism, PCR conditions, etc.) was obtained from the Genome Database. The reactions were performed on 250 ± 500 ng DNA, in 50 ml reaction volume (containing 10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl 2 , 0.25 mM of each dNTP and 0.2 units of Taq polymerase), as well as the dierent STS-speci®c primers. After initial heating to 948C for 5 min, followed by 30 ± 35 cycles of DNA denaturation (1 min at 948C), annealing (1 min at 558C, 588C or 608C depending on the primer set used) and extension (1 min at 728C), ®nal extension was performed at 728C for 10 min. Five ml of the volume was analysed by electrophoresis on a 3% agarose gel (50% regular and 50% NuSieve GTG agarose) and ethidium bromide staining. The dierent PCR products were isolated from gel using the Quiaquick Gel Extraction Kit (Quiagen). Subsequently, 100 ng was radioactively labeled using random primed labeling and hybridized to the chromosome 12-speci®c cosmid-library. Sonicated placental DNA was used to reduce background staining. In addition, CA repeat containing STS fragments were prehybridized with other CA repeat-containing probes for 1 h in 56 SSC. For STS fragments smaller than 200 bp, end-labeled oligo's were used as probe. Positive cosmid clones were checked for their speci®city for the relevant STS by PCR using 50 ng cosmid DNA. In addition, the cosmids were tested for their suitability for FISH on normal lymphocyte-preparations.
FISH: labeling of the probes and hybridization
The single and bicolour-FISH experiments were performed as described earlier (Mostert et al., 1996b) using YAC#5 and either one of the other YACs or cosmids as probe. YAC#5 was puri®ed by pulsed ®eld gel electrophoresis, ampli®ed and labeled with digoxigenin-11-dUTP (GIBCO ± BRL) as reported before. The other probes were labeled using a standard nick-translation kit (GIBCO ± BRL) with biotin-11-dUTP. One hundred ng of both labeled probes and 0.5 mg COT 1 DNA (GIBCO ± BRL) were dissolved in 10 ml standard hybridization mixture containing 50% formamide/26 SSC/10% dextransulphate. The slides were prepared from methanol-acetic acid ®xed sediment from cases T2814, T8763 and T202 and from ethanol ®xed suspensions containing nuclei from frozen tissue of cases T10077, T3035, T2207, T2655 and T60. Before hybridization, the slides were pretreated as follows: the methanol/acetic acid ®xed slides were rinsed in water and incubated in 50% HAc/H 2 O and 50% HAc/ MeOH for 4 min respectively and airdried. The slides were dehydrated in 70% ethanol (08C) and subsequently in 80%, 90% and 100% at room temperature for 3 min, respec-tively. After air-drying, the slides were treated with RNase (0.1 mg/ml) (SIGMA) in 26 SSC for 30 min at room temperature and rinsed in 26 SSC. The ethanol ®xed slides were incubated in 0.1 mg/ml pepsine in 0.01% HCL (SIGMA) for 20 min at 378C. After rinsing in water and PBS, ®ve times each, the nuclei were post-®xed with 1% formaldehyde in PBS for 10 min at 48C. After another ®ve rinses with PBS the nuclei were dehydrated in 70%, 80%, 90% and 100% ethanol, respectively. After in situ hybridization for 48 h at 378C, the biotin labeled probes were visualized by a new detection method with biotinyltyramide (Raap et al., 1995) with a few modi®cations. Brie¯y, the slides were incubated with ABC (DAKO) streptavidin-peroxide for 30 min at room temperature. Following washes with PBS/0.1% Tween, the biotinyltyramide solution (NEP-116 kit of Dupont) 1 : 200 ± 1 : 400, 0.01% H 2 O 2 in PBS was incubated for 10 min at room temperature. After enzymatic reaction, probe YAC#5 was visualized with¯uorescein isothiocyanate (FITC) conjugated sheep-a-digoxigenin (Boehringer) and the biotin labeled probe with avidin-CY3 (Jacksons Immunoresearch Laboratories).
For every tumor, 30 nuclei with ampli®cation of YAC#5 were analysed by three dierent investigators. In each nucleus, the number of hybridization signals of YAC#5 (green) was compared to the number of signals of the other probe (detected in red).
Mapping of candidate genes and expression analysis
LGS-speci®c primers were generated within the 3'UTR (positions 2349 ± 2368 and 2610 ± 2631, GENBank accession number S70004), with the following sequences: LGS1: 5'-AGTTAGGCATGAGGAGGAGC-3', and LGS2: 5'-AATCATGGTTCTGATGCATGTG-3'. The primers used for SOX5 were SOX5f2 (5'-CACTGCTGGTGTTGTG-TAC-3') and 2E2reva (Wunderle et al., 1996) , and for KRAS2 KR1 (5'-TGATAGTGTATTAACCTTATG-3') and KR2 (5'-TTTATCTGTATCAAAGAATG-3') (both in exon 1). The primers for JAW1 (5'-CAGCAGGACATCC-TAATATATGG-3' and 5'-CCCATTGTATTTTAGTTG-GGG-3') were the STS primers for D12S1350E. The PCR experiments were performed as described in the Results section.
RT ± PCR was performed on total RNA isolated from approximately ®ve tissue sections of 50 mm thickness of the snap-frozen samples, using RNA STAT-60 (TEL-TEST). Of every sample, two 5 mm sections (the ®rst and the last in the series) were stained with hematoxylin and eosin for microscopic analysis of the histological composition. After treatment of the RNA with RNase-free DNase (Boehringer), phenol/chloroform extraction and precipitation, 5 mg of total RNA was reverse transcribed at 378C for 2 h in a total volume of 40 ml containing 1 mM each dNTP (Pharmacia), 1 mM dithiothreitol, 1.2 mg random hexamer primers (pd[N]6) (Pharmacia), 1.2 mg oligo d(T) primer d[T]12-18 (Pharmacia), 4.5 U of RNasin (Pharmacia), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 and 1 ml of Superscript RNAse H 7 RT (BRL; 200 U/ml). Absence of contaminating DNA was checked by PCR without prior reverse transcription. Integrity of the cDNA was tested via ampli®cation of Hypoxanthine Phospho-Ribosyl-Transferase (HPRT) transcripts (28 cycles), with primers 244 and 246 as published before (Gibbs et al., 1989) (5'-AATTATGGACAGGACT-GAACGTC-3' and 5'-GGCGATGTCAATAGGACTCCA-GATG-3', respectively), generating a fragment of 587 bp. Ampli®cation was performed using 1.5 ml of the same reverse transcription reaction mix in a total volume of 50 ml containing 16 Taq DNA polymerase buer with 1.5 mM MgCl 2 , 25 pmol of each primer, 0.2 mM each dNTP and 1 U of Taq DNA polymerase (Promega). After an initial denaturation of 4 min at 948C, every ampli®cation cycle consisted (in total 32) of 1 min at 958C, 1 min at 648C and 1.5 min at 728C. PCR products were visualized on 3% (50% regular and 50% NuSieve GTG (FMC)) agarose gels stained with ethidium bromide. This was also used as reference for the level of expression of SOX5 and KRAS2. The primers used for SOX5 (spanning an intron) were SOX5fore and 2E2reva (Wunderle et al., 1996) , generating a fragment of 477 bp. Primers (spanning two introns) used for KRAS were KR11 in exon1 (5'-GAGTGCCTTGACGATACAGCT-3') and KR12 in exon 3 (5'-CTTTGCTGATGTTTCAATAA-AAGG-3'), generating a fragment of 394 bp. Ampli®cation of SOX5 and KRAS2 transcripts was done using an initial denaturation of 5 min at 948C, and subsequently 35 cycles consisted of 45 s 948C, 30 s 608C and 30 s 728C, and ®nally 10 min at 728C for SOX5 and after initial denaturation 35 cycles consisted of 1 min 948C, 1 min 588C and 1 min 728C, and ®nally 10 min at 728C, for KRAS2.
Semi-quantitative PCR
The semi-quantitative PCR was performed as described before . Besides the seven TGCTs with the ampli®cation of 12p sequences, seven TGCTs without such ampli®cations were included as controls. The cases were studied under code not knowing the origin of the samples. The progesterone receptor (ProgR), which maps to 11q23 and the 17pTEL STS, were included in every experiment as references (Bettincher et al., 1996; White et al., 1996) . The following target genes were studied: LGS, KRAS2, KRAG (primers 021/022) and ITPR2. Brie¯y, for each PCR 0.5 mg tumor DNA was ampli®ed in a 100 ml reaction with 0.5 mg of each primer (two primer pairs) in standard reaction mix over 30 cycles of 1 min at 55 ± 608C, 1 min at 748C, 1 min at 948C and ®nal steps of 1 min at 55 ± 608C and 10 min 748C. After gel electrophoresis (2% agarose), relative band intensities of PCR products (test versus control) were compared visually, with reference to band intensities derived from normal genomic DNA controls.
